ICAP at Columbia University has received $25 million in the first year of a $125 million, five-year award from the “U.S. Centers for Disease Control and Prevention”:http://www.cdc.gov/ to conduct national, population-based HIV impact assessments (PHIAs) in 20 countries in sub-Saharan Africa. These surveys will provide critical information on the state of the HIV epidemic in these countries and help shape policies and programs to confront the epidemic. The findings may also help inform global funding priorities.
After a decade of successful scale-up of HIV prevention and treatment efforts in sub-Saharan Africa, there is a great deal of interest in looking at what has been accomplished to date, understanding the effect HIV programs have had on the trajectory of the epidemic and how such information may be used to modify the response to the epidemic in the coming years. Household-based, population-level surveys will address these key areas by using biologic markers to measure HIV prevalence, incidence and to estimate access to prevention, care and treatment services. The findings from these surveys will provide a deeper understanding of the impact of the HIV response at a national level and will guide future investments and help target programs and resources for priority populations at greatest risk and in most need of services.
“We have an important opportunity to gather and use population-based data, much like a census focused on HIV, to get a better picture of the HIV epidemic in Africa,” said Dr. Jessica Justman, principal investigator and senior technical director at ICAP. “This project will yield a body of evidence and lessons learned to inform HIV programs over the next decade.”
The PHIA Project, led by ICAP, includes other key partners: the African Society for Laboratory Medicine, ICF International, Statistical Center for HIV/AIDS Research and Prevention at the Fred Hutchinson Cancer Center, University of California San Francisco’s Global Health Sciences and Westat. The team has presence in each of the 20 countries and will work in collaboration with local and regional governments in the survey planning and implementation, as well as analysis and dissemination of results.
ICAP will provide technical support to strengthen data collection systems and enhance laboratory infrastructure in the countries where the surveys will be conducted. An additional and important aspect of this project is enhancing capacity within countries to design, conduct, and analyze PHIAs and to use findings in policy development and program design.
“This is an opportune moment to take stock of what has been achieved in confronting the HIV epidemic in Africa and to use rigorous methods to collect the type of information we need to guide the way forward,” added Wafaa El-Sadr, ICAP director. An External Advisory Group of distinguished academic, policy and organizational leaders from the global north and south will provide guidance to the project and help generate and disseminate global and local HIV programmatic and policy recommendations.
The PHIA Project builds on ICAP’s previous experience in designing and implementing similar HIV surveys in Tanzania, Zambia and in the conduct of a large-scale population survey in “Swaziland”:https://icap.columbia.edu/where-we-work/swaziland that included over 13,000 participating households. ICAP launched the “Swaziland HIV Incidence Measurement Survey website”:http://shims.icap.columbia.edu/ earlier this year, making select data and survey findings available online to researchers.
Founded in 2004, ICAP at Columbia University supports programs and research that address major health issues such as HIV, malaria, tuberculosis, maternal and child health and non-communicable diseases. ICAP works in collaboration with partners around the world to support high-performing health system strengthening initiatives and implements innovative and sustainable health solutions. ICAP, situated at the Columbia Mailman School of Public Health, works in partnership with governmental and non-governmental organizations and is currently working in more than 3,300 health facilities across 21 countries.